Dr. Thimmiah Kumar , MD
Specialist • Ocala, FL
1950 Sw 18th Ct, Suite 101
Ocala, FL 344717857
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 6, 2005; this date does not establish years in practice.
-
Published CMS data list 2,813 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 826 service units.
- 88305 — Pathology examination of tissue using a microscope, intermediate complexity: 751 service units.
- 88312 — Special stained specimen slides to identify organisms including interpretation and report: 379 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 14 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,708 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Omeprazole — 929 prescription fills, including refills.
- Lansoprazole — 384 prescription fills, including refills.
- Metronidazole — 279 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 34 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: 1,487. Middle half: 453 to 3,647.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,617 in 2020 to 2,813 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1950 Sw 18th Ct
Suite 101
Ocala, FL 344717857
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Thimmiah Kumar Md Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1983
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
482 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $324,193 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $253,401 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
6,625 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,120,176 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,497.18 across 100 records.
By nature of payment
- Food and Beverage: $1,497.18 across 100 records.
Reporting-company totals (3 largest of 14)
- ABBVIE INC.: $378.28 across 31 records.
- Pfizer Inc.: $216.80 across 11 records.
- Takeda Pharmaceuticals U.S.A., Inc.: $201.29 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
43 years (graduated 1983)
CMS Doctors and Clinicians data list 1983 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Kumar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Kumar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ocala and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: 1,487. Middle half: 453 to 3,647.
Too few clinicians listed under Specialist in Ocala have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: $129,953. Middle half: $43,519 to $280,097.
Too few clinicians listed under Specialist in Ocala have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Specialist in Florida (2024, 456 clinicians with data). Median for this group: $96,632. Middle half: $32,296 to $209,932.
Too few clinicians listed under Specialist in Ocala have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Specialist in Florida (2024, 508 clinicians with data). Median for this group: 602. Middle half: 126 to 2,340.
Too few clinicians listed under Specialist in Ocala have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Specialist in Florida (2024, 508 clinicians with data). Median for this group: $35,772. Middle half: $2,466 to $359,998.
Too few clinicians listed under Specialist in Ocala have Medicare Part D data for 2024 to compare.
43 active clinicians are listed under Specialist with a practice address in Ocala, FL (2,695 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Ocala
2.3% of these 43 clinicians have the CMS telehealth indicator.
18.6% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 22% from 3,617 in 2020 to 2,813 in 2024.
- 2020: 3,617
- 2021: 2,813
- 2022: 3,378
- 2023: 2,862
- 2024: 2,813
-
Medicare-allowed amount
Medicare-allowed amount decreased 15% from $382,860 in 2020 to $324,193 in 2024.
- 2020: $382,860
- 2021: $324,648
- 2022: $372,587
- 2023: $320,065
- 2024: $324,193
-
Paid by Medicare
Paid by Medicare decreased 15% from $298,260 in 2020 to $253,401 in 2024.
- 2020: $298,260
- 2021: $248,794
- 2022: $287,053
- 2023: $248,347
- 2024: $253,401
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 27% from 2,927 in 2020 to 3,708 in 2024.
- 2020: 2,927
- 2021: 2,735
- 2022: 3,619
- 2023: 3,605
- 2024: 3,708
-
30-day fills
30-day fills increased 12% from 5,902 in 2020 to 6,625 in 2024.
- 2020: 5,902
- 2021: 5,526
- 2022: 6,939
- 2023: 6,741
- 2024: 6,625
-
Part D drug cost
Part D drug cost increased 191% from $384,950 in 2020 to $1,120,176 in 2024.
- 2020: $384,950
- 2021: $445,270
- 2022: $629,494
- 2023: $615,398
- 2024: $1,120,176
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $991.03 in 2021 to $1,497.18 in 2025.
- 2021: $991.03
- 2022: $953.55
- 2023: $1,216.82
- 2024: $1,228.75
- 2025: $1,497.18
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 100 records totaling $1,497.18.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $120.84 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $34.24 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $33.34 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
ZENPEP | General | $33.25 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $32.99 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $31.75 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $29.68 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.57 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $28.89 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $28.26 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.83 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $26.61 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $26.24 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $26.20 |
| Intercept Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OCALIVA | General | $25.32 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $23.57 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $22.94 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $22.94 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $22.47 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.34 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $22.22 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $22.22 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $22.04 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $22.00 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $21.89 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
826 | 385 | $318.00 | $131.62 |
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
751 | 190 | $174.00 | $72.21 |
|
88312
Special stained specimen slides to identify organisms including interpretation and report
|
379 | 152 | $271.00 | $112.13 |
|
88313
Special stained specimen slides to examine tissue including interpretation and report
|
252 | 147 | $197.00 | $82.38 |
|
43239
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope
|
221 | 195 | $928.00 | $103.50 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
153 | 153 | $417.00 | $171.56 |
|
45385
Removal of polyps or growths of large bowel using an endoscope with mechanical snare
|
67 | 67 | $1131.00 | $252.89 |
|
45380
Biopsy of large bowel using a flexible endoscope
|
41 | 41 | $1076.00 | $157.32 |
|
43248
Insertion of guide wire with dilation of esophagus using a flexible endoscope
|
26 | 24 | $1020.00 | $153.26 |
|
45378
Diagnostic exam of large bowel using a flexible endoscope
|
24 | 23 | $847.00 | $173.02 |
|
45331
Biopsy of lower large bowel using a flexible endoscope
|
22 | 22 | $700.00 | $60.10 |
|
G0105
Colorectal cancer screening; colonoscopy on individual at high risk
|
20 | 20 | $847.00 | $195.33 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
19 | 17 | $438.00 | $180.63 |
|
91110
Imaging of digestive tract done from the inside of the digestive tract
|
12 | 12 | $1794.00 | $722.86 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Omeprazole | Omeprazole | 929 | 68,166 | $16,853.39 | 355 |
| Lansoprazole | Lansoprazole | 384 | 28,341 | $15,124.03 | 169 |
| Metronidazole | Metronidazole | 279 | 2,753 | $2,116.01 | 221 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 259 | 2,607 | $2,104.56 | 206 |
| Famotidine | Famotidine | 222 | 16,278 | $2,512.09 | 95 |
| Linzess | Linaclotide | 222 | 10,170 | $180,174.10 | 71 |
| Metoclopramide Hcl | Metoclopramide Hcl | 212 | 5,965 | $714.10 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 180 | 13,291 | $3,286.46 | 71 |
| Colestipol Hcl | Colestipol Hcl | 118 | 4,945 | $9,398.53 | 55 |
| Zenpep | Lipase/Protease/Amylase | 113 | 3,756 | $452,353.58 | 25 |
| Dicyclomine Hcl | Dicyclomine Hcl | 67 | 2,902 | $1,632.20 | 31 |
| Creon | Lipase/Protease/Amylase | 64 | 2,002 | $179,737.66 | 14 |
| Ondansetron Odt | Ondansetron | 61 | 1,705 | $1,768.31 | 34 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | 2,855 | $1,383.15 | 14 |
| Sucralfate | Sucralfate | 47 | 2,660 | $1,482.13 | 20 |
| Fluconazole | Fluconazole | 44 | 508 | $662.39 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 971 | $1,777.05 | 22 |
| Lactulose | Lactulose | 33 | 968 | $405.87 | — |
| Budesonide Dr | Budesonide | 33 | 1,225 | $6,446.73 | 19 |
| Vancomycin Hcl | Vancomycin Hcl | 32 | 314 | $5,093.79 | 28 |
| Amoxicillin | Amoxicillin | 31 | 401 | $98.79 | 25 |
| Cefuroxime | Cefuroxime Axetil | 31 | 270 | $468.45 | 28 |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 400 | $229.73 | 23 |
| Voquezna | Vonoprazan Fumarate | 29 | 1,310 | $28,870.69 | — |
| Levofloxacin | Levofloxacin | 27 | 262 | $120.08 | 26 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20051007000501
FL
9133152192
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Thimmiah Kumar Md Pa
1950 Sw 18th Ct, Ocala, FL 344717857
Phone: 3523048986
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Advanced Registered Nurse Practitioner
Career & Practice History
NPI enumerated September 06, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Ocala
- Dr. Samantha Johnson, DNP
- Dr. Keertini Kumar, MD
- Dr. Paul Jo, MD
- Adam Geril, PT
- Dr. Nagender Reddy, MD
- Dr. James Paraiso, DO
Mailing Address
Po Box 606
Ocala, FL 344780606
Phone: 3528618555